Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice (PENEDIAB)

University Hospital, Lille

Status

Begins enrollment in 4 months

Conditions

Renal Insufficiency and Diabetes Mellitus

Treatments

Other: training and audit

Other: Routine care

Study type

Interventional

Funder types

Other

Identifiers

NCT05749679

2021_0864

2022-A01698-35 (Other Identifier)

Details and patient eligibility

About

This work will make it possible to identify the nephron loss of type 2 diabetic patients in the western region and to better define in general practice the impact of the elements put in place to reduce this loss and to raise awareness of the importance of these measures through training in comparison with a control group.

Enrollment

360 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient consulting his or her investigating general practitioner
50 years old or more
type 2 diabetic for more than 5 years, with a GFR lower than 90 ml/mn and higher than 45 ml/mn (stage 2 and 3a of renal failure) and a nephron loss calculated on the average of the two previous years, higher than 3 ml/mn/year
a microalbuminuria > 30 mg/gr of creatinuria.
Having declared the investigator as the treating physician

Exclusion criteria

Patient under 50 years of age Patients who do not agree to the use of their data (refusal of consent) or are unable to give consent (dementia, other) Patients with other types of diabetes Patients with renal failure other than diabetic or hypertensive glomerulopathy Patients unable to give consent Patients who do not understand the French language Patients with less than 3 months of planned follow-up Patients with a barrier to follow-up Patients undergoing dialysis, transplantation